What Researchers Did
This study investigated the efficacy of hyperbaric oxygen therapy for early hepatic artery thrombosis after pediatric liver transplantation by comparing outcomes in treated patients to a historical control group.
What They Found
Out of 375 pediatric patients undergoing 416 liver transplantations, 31 (7.5%) developed hepatic artery thrombosis at a mean of 8.2 days post-transplant. Seventeen of these patients received hyperbaric oxygen therapy, while 12 patients served as a control group.
What This Means for Canadian Patients
Hyperbaric oxygen therapy could potentially offer a non-surgical option to improve outcomes for Canadian children experiencing hepatic artery thrombosis after liver transplantation. This may reduce the need for urgent retransplantation and improve survival rates in this vulnerable patient population.
Canadian Relevance
This study was not conducted in Canada and does not have direct Canadian relevance.
Study Limitations
The study's retrospective design and relatively small sample size for the intervention groups limit the generalizability of its findings.